Bank of America’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.47M | Sell |
25,646
-4,665
| -15% | -$467K | ﹤0.01% | 3969 |
|
|
2025
Q4 | $2.95M | Buy |
30,311
+9,888
| +48% | +$848K | ﹤0.01% | 3771 |
|
|
2025
Q3 | $1.45M | Sell |
20,423
-1,717
| -8% | -$114K | ﹤0.01% | 5082 |
|
|
2025
Q2 | $1.32M | Sell |
22,140
-249
| -1% | -$13.6K | ﹤0.01% | 5099 |
|
|
2025
Q1 | $1.17M | Sell |
22,389
-3,582
| -14% | -$201K | ﹤0.01% | 5111 |
|
|
2024
Q4 | $1.43M | Buy |
25,971
+1,949
| +8% | +$103K | ﹤0.01% | 4738 |
|
|
2024
Q3 | $1.21M | Buy |
24,022
+8,819
| +58% | +$407K | ﹤0.01% | 4930 |
|
|
2024
Q2 | $668K | Buy |
15,203
+1,716
| +13% | +$73K | ﹤0.01% | 5159 |
|
|
2024
Q1 | $593K | Buy |
13,487
+239
| +2% | +$10.6K | ﹤0.01% | 5247 |
|
|
2023
Q4 | $629K | Buy |
13,248
+4,759
| +56% | +$200K | ﹤0.01% | 5325 |
|
|
2023
Q3 | $377K | Buy |
8,489
+3,465
| +69% | +$161K | ﹤0.01% | 5516 |
|
|
2023
Q2 | $240K | Sell |
5,024
-3,283
| -40% | -$148K | ﹤0.01% | 5723 |
|
|
2023
Q1 | $327K | Buy |
8,307
+3,306
| +66% | +$120K | ﹤0.01% | 5649 |
|
|
2022
Q4 | $141K | Buy |
5,001
+2,942
| +143% | +$84.2K | ﹤0.01% | 6102 |
|
|
2022
Q3 | $62K | Sell |
2,059
-4,592
| -69% | -$160K | ﹤0.01% | 6572 |
|
|
2022
Q2 | $226K | Buy |
6,651
+3,046
| +84% | +$109K | ﹤0.01% | 6002 |
|
|
2022
Q1 | $162K | Sell |
3,605
-6,519
| -64% | -$301K | ﹤0.01% | 6591 |
|
|
2021
Q4 | $467K | Sell |
10,124
-2,502
| -20% | -$101K | ﹤0.01% | 5932 |
|
|
2021
Q3 | $423K | Buy |
12,626
+1,866
| +17% | +$63.5K | ﹤0.01% | 5783 |
|
|
2021
Q2 | $317K | Sell |
10,760
-3,408
| -24% | -$93.9K | ﹤0.01% | 5765 |
|
|
2021
Q1 | $365K | Sell |
14,168
-159
| -1% | -$3.8K | ﹤0.01% | 5620 |
|
|
2020
Q4 | $326K | Buy |
14,327
+1,091
| +8% | +$25.2K | ﹤0.01% | 5284 |
|
|
2020
Q3 | $283K | Sell |
13,236
-437
| -3% | -$9.81K | ﹤0.01% | 5085 |
|
|
2020
Q2 | $317K | Buy |
13,673
+5,301
| +63% | +$114K | ﹤0.01% | 4959 |
|
|
2020
Q1 | $179K | Sell |
8,372
-280
| -3% | -$6.67K | ﹤0.01% | 5145 |
|
|
2019
Q4 | $202K | Sell |
8,652
-15,618
| -64% | -$365K | ﹤0.01% | 5637 |
|
|
2019
Q3 | $510K | Buy |
24,270
+7,607
| +46% | +$155K | ﹤0.01% | 5071 |
|
|
2019
Q2 | $341K | Sell |
16,663
-815
| -5% | -$19.2K | ﹤0.01% | 5317 |
|
|
2019
Q1 | $490K | Sell |
17,478
-2,054
| -11% | -$53.8K | ﹤0.01% | 5030 |
|
|
2018
Q4 | $477K | Buy |
19,532
+3,882
| +25% | +$104K | ﹤0.01% | 4964 |
|
|
2018
Q3 | $582K | Buy |
15,650
+857
| +6% | +$23.1K | ﹤0.01% | 4847 |
|
|
2018
Q2 | $307K | Buy |
14,793
+14,406
| +3,722% | +$255K | ﹤0.01% | 5174 |
|
|
2018
Q1 | $6K | Buy |
+387
| New | +$5.51K | ﹤0.01% | 6730 |
|
|
2017
Q3 | – | Sell |
-1,637
| Closed | -$14K | – | 7152 |
|
|
2017
Q2 | $14K | Sell |
1,637
-47
| -3% | -$401 | ﹤0.01% | 6332 |
|
|
2017
Q1 | $15K | Buy |
1,684
+1,129
| +203% | +$10.5K | ﹤0.01% | 6414 |
|
|
2016
Q4 | $6K | Sell |
555
-473
| -46% | -$5.09K | ﹤0.01% | 6664 |
|
|
2016
Q3 | $17K | Sell |
1,028
-2,931
| -74% | -$54.3K | ﹤0.01% | 6193 |
|
|
2016
Q2 | $86K | Buy |
+3,959
| New | +$71.2K | ﹤0.01% | 5596 |
|
|
2016
Q1 | – | Sell |
-5,414
| Closed | -$152K | – | 7153 |
|
|
2015
Q4 | $152K | Buy |
5,414
+841
| +18% | +$23.8K | ﹤0.01% | 5536 |
|
|
2015
Q3 | $111K | Buy |
4,573
+1,494
| +49% | +$35.7K | ﹤0.01% | 5622 |
|
|
2015
Q2 | $72K | Buy |
3,079
+79
| +3% | +$1.44K | ﹤0.01% | 5765 |
|
|
2015
Q1 | $46K | Hold |
3,000
| – | – | ﹤0.01% | 5698 |
|
|
2014
Q4 | $39K | Buy |
+3,000
| New | +$25.9K | ﹤0.01% | 6475 |
|
Other funds holding IRMD
CCM
VCM
NTCM
Bank of America's IRMD Position: Q1 2026 in Review
Bank of America reduced its iRadimed (IRMD) stake by 15% in Q1 2026, selling an estimated $467K and leaving 25,646 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3969.
Bank of America first reported a position in IRMD in Q4 2014 and has held it in 43 quarters since. The position peaked at $2.95M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Bank of America held 25,646 shares of iRadimed worth $2.47M as of Q1 2026.
- Bank of America sold 4,665 iRadimed shares in Q1 2026, an estimated $467K.
- iRadimed made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3969 holding.
- Bank of America first reported a position in iRadimed in Q4 2014 and has held it in 43 quarters since.
- Bank of America's iRadimed position peaked at $2.95M in Q4 2025.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.